International Consensus (ICON): allergic reactions to vaccines

[1]  L. Grohskopf,et al.  Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices—United States, 2018–19 Influenza Season , 2018, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[2]  S. Hiltner.  Adolescents and adults , 1960, Treatment of Cerebral Palsy and Motor Delay.

[3]  Edited by William Atkinson.  EPIDEMIOLOGY AND PREVENTION OF VACCINE-PREVENTABLE DISEASES , 2017 .

[4]  M. Sanz,et al.  Anaphylaxis to pneumococcal vaccine; CRM(197): Novel cause of vaccine allergy , 2016, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.

[5]  K. Bollaerts,et al.  A systematic review and meta-analysis on the safety of newly adjuvanted vaccines among children. , 2016, Vaccine.

[6]  M. Erlewyn-Lajeunesse,et al.  Safety of live attenuated influenza vaccine in young people with egg allergy: multicentre prospective cohort study , 2015, BMJ : British Medical Journal.

[7]  M. Erlewyn-Lajeunesse,et al.  Safety of live attenuated influenza vaccine in atopic children with egg allergy , 2015, The Journal of allergy and clinical immunology.

[8]  F. Strle,et al.  Tick-borne encephalitis: A review of epidemiology, clinical characteristics, and management. , 2015, World journal of clinical cases.

[9]  F. Simons,et al.  Anaphylaxis: Unique aspects of clinical diagnosis and management in infants (birth to age 2 years). , 2015, The Journal of allergy and clinical immunology.

[10]  Daryl R. Cheng,et al.  Pediatric anaphylactic adverse events following immunization in Victoria, Australia from 2007 to 2013. , 2015, Vaccine.

[11]  K. Waibel,et al.  Safe administration of a gelatin-containing vaccine in an adult with galactose-α-1,3-galactose allergy. , 2015, Vaccine.

[12]  T. Platts-Mills,et al.  The alpha-gal story: lessons learned from connecting the dots. , 2015, The Journal of allergy and clinical immunology.

[13]  E. Woo.  Allergic reactions after egg-free recombinant influenza vaccine: reports to the US Vaccine Adverse Event Reporting System. , 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[14]  S. Hills,et al.  Adverse events following vaccination with an inactivated, Vero cell culture-derived Japanese encephalitis vaccine in the United States, 2009-2012. , 2015, Vaccine.

[15]  M. C. Danovaro-Holliday,et al.  Events supposedly attributable to vaccination or immunization during pandemic influenza A (H1N1) vaccination campaigns in Latin America and the Caribbean. , 2015, Vaccine.

[16]  G. De Serres,et al.  Safe vaccination of patients with egg allergy by using live attenuated influenza vaccine. , 2015, The journal of allergy and clinical immunology. In practice.

[17]  Dongmu Zhang,et al.  1068Vaccine Coverage at Milestone Ages among Infants in the United States, 2009-2012 , 2014, Open Forum Infectious Diseases.

[18]  L. Grohskopf,et al.  Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices (ACIP) — United States, 2014–15 Influenza Season , 2014, MMWR. Morbidity and mortality weekly report.

[19]  A. Sheikh,et al.  Anaphylaxis: guidelines from the European Academy of Allergy and Clinical Immunology , 2014, Allergy.

[20]  M. Maglione,et al.  Safety of Vaccines Used for Routine Immunization of US Children: A Systematic Review , 2014, Pediatrics.

[21]  J. Kelso.  Administering influenza vaccine to egg-allergic persons , 2014, Expert review of vaccines.

[22]  D. Skowronski,et al.  Risk factors associated with anaphylaxis and other allergic-like events following receipt of 2009 monovalent AS03-adjuvanted pandemic influenza vaccine in Quebec, Canada. , 2014, Vaccine.

[23]  P. Eigenmann,et al.  Managing a child with possible allergy to vaccine , 2014, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.

[24]  J. Kelso,et al.  Potential food allergens in medications. , 2014, The Journal of allergy and clinical immunology.

[25]  K. Hoppenbrouwers,et al.  Anaphylaxis after vaccination of children: review of literature and recommendations for vaccination in child and school health services in Belgium. , 2014, Vaccine.

[26]  A. Sheikh,et al.  International consensus on (ICON) anaphylaxis , 2014, The World Allergy Organization journal.

[27]  Rino Rappuoli,et al.  Vaccines for the 21st century , 2014, EMBO molecular medicine.

[28]  M. Kulldorff,et al.  Absence of associations between influenza vaccines and increased risks of seizures, Guillain–Barré syndrome, encephalitis, or anaphylaxis in the 2012–2013 season , 2014, Pharmacoepidemiology and drug safety.

[29]  A. Schuchat,et al.  Benefits from Immunization During the Vaccines for Children Program Era — United States, 1994–2013 , 2014, MMWR. Morbidity and mortality weekly report.

[30]  G. Hermansson,et al.  How common are long-lasting, intensely itching vaccination granulomas and contact allergy to aluminium induced by currently used pediatric vaccines? A prospective cohort study , 2014, European Journal of Pediatrics.

[31]  E. Chung.  Vaccine allergies , 2013, Clinical and experimental vaccine research.

[32]  L. Bielory,et al.  101 – Unconventional Theories and Unproven Methods in Allergy , 2014 .

[33]  James F. Jones,et al.  Immediate hypersensitivity reactions following monovalent 2009 pandemic influenza A (H1N1) vaccines: reports to VAERS. , 2013, Vaccine.

[34]  D. Skowronski,et al.  Increased risk of anaphylaxis following administration of 2009 AS03-adjuvanted monovalent pandemic A/H1N1 (H1N1pdm09) vaccine. , 2013, Vaccine.

[35]  D. Dorward,et al.  Middleton’s Allergy: Principles and Practice , 2013 .

[36]  A. Tozzi,et al.  Assessment of causality of individual adverse events following immunization (AEFI): a WHO tool for global use. , 2013, Vaccine.

[37]  R. Wood,et al.  Allergic reactions to vaccines , 2013, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.

[38]  U. Kunze,et al.  Tick-borne encephalitis: a disease neglected by travel medicine. , 2013, Travel medicine and infectious disease.

[39]  A. Díaz‐Perales,et al.  Diagnosis and Management of Grain-Induced Asthma , 2013, Allergy, asthma & immunology research.

[40]  J. Temte,et al.  Prevention of measles, rubella, congenital rubella syndrome, and mumps, 2013: summary recommendations of the Advisory Committee on Immunization Practices (ACIP). , 2013, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[41]  J. Kelso.  Allergic reactions after immunization. , 2013, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[42]  M. Gillstedt,et al.  Unexpected loss of contact allergy to aluminium induced by vaccine , 2013, Contact dermatitis.

[43]  S. Nasser,et al.  Administration of Yellow Fever Vaccine in Patients with Egg Allergy , 2013, International Archives of Allergy and Immunology.

[44]  C. Parisi,et al.  Hypersensitivity reactions to the Sabin vaccine in children with cow's milk allergy , 2013, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[45]  I. M. Jørgensen,et al.  MMR vaccination of children with egg allergy is safe. , 2013, Danish medical journal.

[46]  T. Finn,et al.  6 – Vaccine additives and manufacturing residuals in the United States: licensed vaccines , 2013 .

[47]  S. Spector,et al.  Update on influenza vaccination of egg allergic patients , 2013 .

[48]  B. Trollfors,et al.  Sixty-four children with persistent itching nodules and contact allergy to aluminium after vaccination with aluminium-adsorbed vaccines—prognosis and outcome after booster vaccination , 2013, European Journal of Pediatrics.

[49]  D. Skowronski,et al.  Allergic symptoms after pandemic influenza vaccination rarely mediated by vaccine-specific IgE. , 2012, The Journal of allergy and clinical immunology.

[50]  R. O'Sullivan,et al.  A review of a paediatric emergency department vaccination programme for patients at risk of allergy/anaphylaxis , 2012, Acta paediatrica.

[51]  Cornelia L Dekker,et al.  Algorithm to assess causality after individual adverse events following immunizations. , 2012, Vaccine.

[52]  J. Kelso.  Safety of influenza vaccines , 2012, Current opinion in allergy and clinical immunology.

[53]  S. Spector,et al.  Adverse reactions to vaccines practice parameter 2012 update. , 2012, The Journal of allergy and clinical immunology.

[54]  D. Cohen,et al.  Hypersensitivity Reactions to Vaccine Constituents: A Case Series and Review of the Literature , 2012, Dermatitis : contact, atopic, occupational, drug.

[55]  T. Casale,et al.  We call for iCAALL: International Collaboration in Asthma, Allergy and Immunology. , 2012, Journal of Allergy and Clinical Immunology.

[56]  T. Casale,et al.  We Call for iCAALL: International Collaboration in Asthma, Allergy and Immunology , 2012, The World Allergy Organization journal.

[57]  M. Erlewyn-Lajeunesse,et al.  Anaphylaxis as an adverse event following immunisation in the UK and Ireland , 2012, Archives of Disease in Childhood.

[58]  Z. Vajo,et al.  A Reduced-Dose Seasonal Trivalent Influenza Vaccine Is Safe and Immunogenic in Adult and Elderly Patients in a Randomized Controlled Trial , 2012, Clinical and Vaccine Immunology.

[59]  S. Stein,et al.  Local Vaccine Site Reactions and Contact Allergy to Aluminum , 2012, Pediatric dermatology.

[60]  Harry Seifert,et al.  Anaphylaxis following H1N1 pandemic vaccines: safety data in perspective. , 2011, Vaccine.

[61]  Ruihua Yin,et al.  H1N1 and seasonal influenza vaccine safety in the vaccine safety datalink project. , 2011, American journal of preventive medicine.

[62]  R. Rabin,et al.  Comments on cow's milk allergy and diphtheria, tetanus, and pertussis vaccines. , 2011, The Journal of allergy and clinical immunology.

[63]  H. Sampson,et al.  Anaphylaxis to diphtheria, tetanus, and pertussis vaccines among children with cow's milk allergy. , 2011, The Journal of allergy and clinical immunology.

[64]  F. Simons.  Anaphylaxis pathogenesis and treatment , 2011, Allergy.

[65]  K. Desanto,et al.  Public Health Agency of Canada , 2011 .

[66]  M. Cox,et al.  Evaluation of the safety, reactogenicity and immunogenicity of FluBlok® trivalent recombinant baculovirus-expressed hemagglutinin influenza vaccine administered intramuscularly to healthy adults 50-64 years of age. , 2011, Vaccine.

[67]  J. Süss.  Tick-borne encephalitis 2010: epidemiology, risk areas, and virus strains in Europe and Asia-an overview. , 2011, Ticks and tick-borne diseases.

[68]  J. Nelson,et al.  Injection Site and Risk of Medically Attended Local Reactions to Acellular Pertussis Vaccine , 2011, Pediatrics.

[69]  F. Mahoney,et al.  Adverse reactions following immunization with MMR vaccine in children at selected provinces of Iran. , 2011, Archives of Iranian medicine.

[70]  W. King,et al.  Administration of the adjuvanted pH1N1 vaccine in egg-allergic children at high risk for influenza A/H1N1 disease. , 2011, Canadian journal of public health = Revue canadienne de sante publique.

[71]  J. de Blic,et al.  Anaphylaxis to the 23-valent pneumococcal vaccine: a second explored case by means of immediate-reading skin tests with pneumococcal vaccines. , 2010, Vaccine.

[72]  S. Spector,et al.  The diagnosis and management of anaphylaxis practice parameter: 2010 update. , 2010, The Journal of allergy and clinical immunology.

[73]  R. Kagan,et al.  Safe vaccination of patients with egg allergy with an adjuvanted pandemic H1N1 vaccine. , 2010, The Journal of allergy and clinical immunology.

[74]  M. Erlewyn-Lajeunesse,et al.  Can the Brighton Collaboration case definitions be used to improve the quality of Adverse Event Following Immunization (AEFI) reporting? Anaphylaxis as a case study. , 2010, Vaccine.

[75]  A. Helbling,et al.  Vaccine hypersensitivity--update and overview. , 2010, Swiss medical weekly.

[76]  J. Bartra,et al.  Yellow fever vaccine and egg allergy: really a problem? , 2010, Allergy.

[77]  J. Hedrick,et al.  Evaluation of the safety, reactogenicity and immunogenicity of FluBlok trivalent recombinant baculovirus-expressed hemagglutinin influenza vaccine administered intramuscularly to healthy children aged 6-59 months. , 2009, Vaccine.

[78]  R. Wood,et al.  Bovine and porcine gelatin sensitivity in children sensitized to milk and meat. , 2009, The Journal of allergy and clinical immunology.

[79]  N. Cox,et al.  Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009. , 2009 .

[80]  C. Ponvert.  Les réactions d'hypersensibilité allergique et non allergique aux vaccins contenant des anatoxines , 2009 .

[81]  C. Ponvert.  [Allergic and non-allergic hypersensitivity reactions to toxoid-containing vaccines]. , 2009, Archives de pediatrie : organe officiel de la Societe francaise de pediatrie.

[82]  F. Simons,et al.  Anaphylaxis epidemic: fact or fiction? , 2008, The Journal of allergy and clinical immunology.

[83]  C. Dekker,et al.  An Algorithm for Treatment of Patients With Hypersensitivity Reactions After Vaccines , 2008, Pediatrics.

[84]  T. Craig,et al.  Adverse events associated with intranasal influenza vaccine in the United States , 2008, Therapeutic advances in respiratory disease.

[85]  Andrew T. Kroger,et al.  Syncope after vaccination--United States, January 2005-July 2007. , 2008, MMWR. Morbidity and mortality weekly report.

[86]  S. Dreskin,et al.  Thimerosal in influenza vaccine: an immediate hypersensitivity reaction. , 2007, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[87]  J. V. Rafart,et al.  Vacuna triple vírica y alergia al huevo. Experiencia en una unidad de vacunación hospitalaria , 2007 .

[88]  R. Wood,et al.  Irritant skin test reactions to common vaccines. , 2007, The Journal of allergy and clinical immunology.

[89]  S. Halperin,et al.  Hypotonic-hyporesponsive episode (HHE) as an adverse event following immunization in early childhood: case definition and guidelines for data collection, analysis, and presentation. , 2007, Vaccine.

[90]  Jan Bonhoeffer,et al.  Anaphylaxis: case definition and guidelines for data collection, analysis, and presentation of immunization safety data. , 2007, Vaccine.

[91]  M. Braun,et al.  Safety review of the purified chick embryo cell rabies vaccine: Data from the Vaccine Adverse Event Reporting System (VAERS), 1997-2005. , 2007, Vaccine.

[92]  J. Vaqué Rafart,et al.  [MMR vaccine and egg allergy. Experience in a hospital immunization unit]. , 2007, Anales de pediatria.

[93]  J. J. S. Sienra Monge,et al.  [Adverse reactions to vaccines]. , 2007, Revista alergia Mexico.

[94]  R. Hennig,et al.  Neue gelatinefreie FSME-Impfstoffe mit verbessertem Sicherheitsprofil , 2006 .

[95]  S. Mäkinen‐Kiljunen,et al.  Clustered sensitivity to fungi: anaphylactic reactions caused by ingestive allergy to yeasts. , 2006, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[96]  朱丽琳,et al.  Anaphylaxis , 2006 .

[97]  H. Ehrlich,et al.  Safety and immunogenicity of the modified adult tick-borne encephalitis vaccine FSME-IMMUN: results of two large phase 3 clinical studies. , 2006, Vaccine.

[98]  S. Shadomy,et al.  Vaccination of yeast sensitive individuals: review of safety data in the US vaccine adverse event reporting system (VAERS). , 2006, Vaccine.

[99]  D. Hepner,et al.  Second symposium on the definition and management of anaphylaxis: summary report--Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium. , 2006, The Journal of allergy and clinical immunology.

[100]  D. Metze,et al.  Persistent nodules at injection sites (aluminium granuloma)—clinicopathological study of 14 cases with a diverse range of histological reaction patterns , 2006, Histopathology.

[101]  M. Bröker,et al.  [New gelatine-free TBE vaccines with improved safety profile]. , 2006, Klinische Padiatrie.

[102]  N. Cox,et al.  Prevention and Control of Influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). , 2006, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[103]  M. Primeau,et al.  Administering pharmaceuticals to latex-allergic patients from vials containing natural rubber latex closures. , 2005, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

[104]  P. Lieberman.  Biphasic anaphylactic reactions. , 2005, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[105]  D. Skowronski,et al.  Oculo-respiratory syndrome after influenza vaccination: trends over four influenza seasons. , 2005, Vaccine.

[106]  Shinji Kawabe,et al.  Safety and immunogenicity of gelatin-free varicella vaccine in epidemiological and serological studies in Japan. , 2005, Vaccine.

[107]  M. Lee-wong,et al.  A generalized reaction to thimerosal from an influenza vaccine. , 2005, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[108]  J. Kelso,et al.  Vaccination of persons allergic to latex: a review of safety data in the Vaccine Adverse Event Reporting System (VAERS). , 2004, Vaccine.

[109]  H. Kuno-sakai,et al.  Removal of gelatin from live vaccines and DTaP-an ultimate solution for vaccine-related gelatin allergy. , 2003, Biologicals : journal of the International Association of Biological Standardization.

[110]  R. Davis,et al.  Risk of anaphylaxis after vaccination of children and adolescents. , 2003, Pediatrics.

[111]  S. Plevy,et al.  The Incidence and Management of Infusion Reactions to Infliximab: A Large Center Experience , 2003, American Journal of Gastroenterology.

[112]  D. Skowronski,et al.  Oculo-respiratory syndrome: a new influenza vaccine-associated adverse event? , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[113]  T. Mach,et al.  Clinical evaluation of a polygeline-free tick-borne encephalitis vaccine for adolescents and adults. , 2003, Vaccine.

[114]  Robert T. Chen,et al.  Prevalence of anti-gelatin IgE antibodies in people with anaphylaxis after measles-mumps rubella vaccine in the United States. , 2002, Pediatrics.

[115]  P. Orr.  Supplementary statement for the 2002-2003 influenza season: update on oculo-respiratory syndrome in association with influenza vaccination. , 2002, Canada communicable disease report = Releve des maladies transmissibles au Canada.

[116]  L. Jackson,et al.  Retrospective population-based assessment of medically attended injection site reactions, seizures, allergic responses and febrile episodes after acellular pertussis vaccine combined with diphtheria and tetanus toxoids , 2002, The Pediatric infectious disease journal.

[117]  N. Halsey.  The science of evaluation of adverse events associated with vaccination. , 2002, Seminars in pediatric infectious diseases.

[118]  J. Carapetis,et al.  MMR immunisation. True anaphylaxis to MMR vaccine is extremely rare. , 2001, BMJ.

[119]  J. de Blic,et al.  Anaphylaxis to the 23-valent pneumococcal vaccine in child: a case-control study based on immediate responses in skin tests and specific IgE determination. , 2001, Vaccine.

[120]  J. Bousquet,et al.  A revised nomenclature for allergy. An EAACI position statement from the EAACI nomenclature task force. , 2001 .

[121]  J. Bousquet,et al.  A revised nomenclature for allergy: An EAACI position statement from the EAACI nomenclature task force , 2001, Allergy.

[122]  R. Harbour,et al.  A new system for grading recommendations in evidence based guidelines , 2001, BMJ : British Medical Journal.

[123]  M. Paunio,et al.  Allergic reactions to measles-mumps-rubella vaccination. , 2001, Pediatrics.

[124]  M. Broeker,et al.  Immediate allergic reactions after vaccinations – a post-marketing surveillance review , 2001, European Journal of Pediatrics.

[125]  Laurie J. Smith,et al.  Anaphylaxis Complicating Routine Childhood Immunization: Hemophilus Influenza b Conjugated Vaccine , 2000 .

[126]  W. P. Stephenson,et al.  The postmarketing safety profile of varicella vaccine. , 2000, Vaccine.

[127]  J. Kelso.  Raw egg allergy-a potential issue in vaccine allergy. , 2000, The Journal of allergy and clinical immunology.

[128]  D. Greenes,et al.  Biphasic Anaphylactic Reactions in Pediatrics , 2000, Pediatrics.

[129]  M. Sakaguchi,et al.  Systemic allergic reactions to gelatin included in vaccines as a stabilizer. , 2000, Japanese journal of infectious diseases.

[130]  M. Braun,et al.  Postlicensure safety surveillance for varicella vaccine. , 2000, JAMA.

[131]  C. Aizawa,et al.  Change in gelatin content of vaccines associated with reduction in reports of allergic reactions. , 2000, The Journal of allergy and clinical immunology.

[132]  Pumphrey.  Lessons for management of anaphylaxis from a study of fatal reactions , 2000, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[133]  T. Zuberbier,et al.  Gelatin-induced urticaria and anaphylaxis after tick-borne encephalitis vaccine. , 2000, Acta dermato-venereologica.

[134]  G. Lack,et al.  Recommendations for using MMR vaccine in children allergic to eggs , 2000, BMJ : British Medical Journal.

[135]  D. Isaacs,et al.  Adverse events following immunisation associated with the 1998 Australian Measles Control Campaign. , 2000, Communicable diseases intelligence.

[136]  R. Porsche,et al.  Allergy to protamine sulfate. , 1999, Heart & lung : the journal of critical care.

[137]  R. Wood,et al.  Protamine allergy as a complication of insulin hypersensitivity: A case report. , 1999, The Journal of allergy and clinical immunology.

[138]  R. Helm,et al.  Common allergens in avian meats. , 1999, The Journal of allergy and clinical immunology.

[139]  G. Mootrey,et al.  Anaphylaxis from yellow fever vaccine. , 1999, The Journal of allergy and clinical immunology.

[140]  C. Aizawa,et al.  A clinical analysis of gelatin allergy and determination of its causal relationship to the previous administration of gelatin-containing acellular pertussis vaccine combined with diphtheria and tetanus toxoids. , 1999, The Journal of allergy and clinical immunology.

[141]  C. Johnson,et al.  Urticaria following varicella vaccine associated with gelatin allergy. , 1999, Vaccine.

[142]  X. Baur,et al.  Baker's asthma: still among the most frequent occupational respiratory disorders. , 1998, The Journal of allergy and clinical immunology.

[143]  Y. Sakai,et al.  Non-antigenic and low allergic gelatin produced by specific digestion with an enzyme-coupled matrix. , 1998, Biological & pharmaceutical bulletin.

[144]  M. Sakaguchi,et al.  Gelatin-specific humoral and cellular immune responses in children with immediate- and nonimmediate-type reactions to live measles, mumps, rubella, and varicella vaccines. , 1997, The Journal of allergy and clinical immunology.

[145]  M. Sakaguchi,et al.  IgE-mediated systemic reactions to gelatin included in the varicella vaccine. , 1997, The Journal of allergy and clinical immunology.

[146]  M. Sakaguchi,et al.  Systemic immediate-type reactions to gelatin included in Japanese encephalitis vaccines. , 1997, Vaccine.

[147]  M. Sakaguchi,et al.  Food allergy to gelatin in children with systemic immediate-type reactions, including anaphylaxis, to vaccines. , 1996, The Journal of allergy and clinical immunology.

[148]  D. Baxter.  Measles immunization in children with a history of egg allergy. , 1996, Vaccine.

[149]  A. Mora-González,et al.  Baker's asthma caused by Saccharomyces cerevisiae in dry powder form. , 1996, The Journal of allergy and clinical immunology.

[150]  M. Sakaguchi,et al.  IgE antibody to gelatin in children with immediate-type reactions to measles and mumps vaccines. , 1995, The Journal of allergy and clinical immunology.

[151]  S. Kumar,et al.  Adverse reactions after measles vaccination in India. , 1995, The National medical journal of India.

[152]  J. English,et al.  Anaphylaxis after hepatitis B vaccination , 1995, The Lancet.

[153]  P. Roberson,et al.  Safe administration of the measles vaccine to children allergic to eggs. , 1995, The New England journal of medicine.

[154]  L. Schwartz,et al.  Elevated serum tryptase levels in a patient with protracted anaphylaxis. , 1994, Annals of allergy.

[155]  L. W. Hunt,et al.  Extractable latex allergens and proteins in disposable medical gloves and other rubber products. , 1994, The Journal of allergy and clinical immunology.

[156]  D. Nalin.  Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality , 1994, The Yale Journal of Biology and Medicine.

[157]  W. Roper,et al.  Prevention and control of influenza: Part I, Vaccines. Recommendations of the Advisory Committee on Immunization Practices (ACIP). , 1994, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[158]  J. Kelso,et al.  Anaphylaxis to measles, mumps, and rubella vaccine mediated by IgE to gelatin. , 1993, The Journal of allergy and clinical immunology.

[159]  H. Sampson,et al.  Egg hypersensitivity and adverse reactions to measles, mumps, and rubella vaccine. , 1992, The Journal of pediatrics.

[160]  P. Giampietro,et al.  Safety of measles immunisation in children with IgE-mediated egg allergy , 1990, The Lancet.

[161]  Henry Nider,et al.  Report of the Committee on Infectious Diseases , 1989 .

[162]  H. Majchrowicz.  [Post-vaccination reactions to diploid rabies vaccine]. , 1989, Przeglad epidemiologiczny.

[163]  S. Hewitt,et al.  General recommendations on immunization. , 1989, MMWR. Morbidity and mortality weekly report.

[164]  Larry K. Pickering,et al.  General recommendations on immunization. , 2006, MMWR. Morbidity and mortality weekly report.

[165]  R. Schneiderman,et al.  Allergic reactions to measles (rubeola) vaccine in patients hypersensitive to egg protein. , 1983, The Journal of pediatrics.

[166]  G. Legwold,et al.  THE AMERICAN ACADEMY OF PEDIATRICS , 1982, The Physician and sportsmedicine.

[167]  N. Tauraso,et al.  Quantitation of residual host protein in chicken embryo-derived vaccines by radial immunodiffusion. , 1971, Applied microbiology.